The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3'-(5-((1H-indol-3-yl)methyl)-1,2,4-oxadiazol-3-yl)biphenyl-4-ol ID: ALA3759694
PubChem CID: 127027703
Max Phase: Preclinical
Molecular Formula: C23H17N3O2
Molecular Weight: 367.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Oc1ccc(-c2cccc(-c3noc(Cc4c[nH]c5ccccc45)n3)c2)cc1
Standard InChI: InChI=1S/C23H17N3O2/c27-19-10-8-15(9-11-19)16-4-3-5-17(12-16)23-25-22(28-26-23)13-18-14-24-21-7-2-1-6-20(18)21/h1-12,14,24,27H,13H2
Standard InChI Key: JCGGXQINPNNNIK-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 32 0 0 0 0 0 0 0 0999 V2000
3.6552 -2.9294 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2542 -4.2907 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.7448 -4.1226 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.0456 -2.6531 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7409 -1.9129 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4119 -2.0324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6896 -2.8088 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0047 -2.0874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0375 -0.5877 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7552 0.1905 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4400 -0.5309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2877 -2.8660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2573 -4.3657 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5409 -5.1419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8549 -4.4184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8853 -2.9187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6017 -2.1426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8817 -5.0394 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.1855 -2.6254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 -1.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5889 0.0182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7138 1.2033 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3155 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0028 -1.5132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.2917 -0.7475 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 2 0
4 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
8 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
15 18 1 0
19 1 1 0
20 19 1 0
21 20 2 0
22 21 1 0
23 22 1 0
24 23 2 0
25 24 1 0
26 25 2 0
27 26 1 0
28 27 2 0
28 23 1 0
20 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 367.41Molecular Weight (Monoisotopic): 367.1321AlogP: 5.18#Rotatable Bonds: 4Polar Surface Area: 74.94Molecular Species: NEUTRALHBA: 4HBD: 2#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.86CX Basic pKa: ┄CX LogP: 5.66CX LogD: 5.66Aromatic Rings: 5Heavy Atoms: 28QED Weighted: 0.46Np Likeness Score: -0.95
References 1. Zhang L, Jiang CS, Gao LX, Gong JX, Wang ZH, Li JY, Li J, Li XW, Guo YW.. (2016) Design, synthesis and in vitro activity of phidianidine B derivatives as novel PTP1B inhibitors with specific selectivity., 26 (3): [PMID:26774579 ] [10.1016/j.bmcl.2015.12.097 ]